|
Mar 3
|
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results
|
|
Feb 26
|
Biodesix to Present at TD Cowen 45th Annual Health Care Conference
|
|
Oct 7
|
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
|
|
Jul 24
|
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
|
|
May 28
|
Biodesix to Participate in Two Investor Conferences in June
|
|
May 11
|
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price
|
|
May 10
|
Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
|
|
May 10
|
Biodesix First Quarter 2024 Earnings: Beats Expectations
|
|
May 9
|
Biodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
|
|
May 8
|
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 8
|
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
|
|
May 7
|
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
|
|
Apr 24
|
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
|
|
Apr 13
|
The recent US$4.0m market cap decrease is likely to have disappointed insiders invested in Biodesix, Inc. (NASDAQ:BDSX)
|
|
Apr 9
|
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
|
|
Apr 5
|
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
|
|
Mar 25
|
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
|
|
Mar 4
|
Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript
|
|
Nov 27
|
Zacks Industry Outlook Highlights Medpace, Doximity and Biodesix
|